Neisseria Meningitidis Vaccine 0.5 mL Vial

Neisseria Meningitidis Vaccine 0.5 mL Vial

The Neisseria Meningitidis Vaccine is designed for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135. This vaccine is suitable for individuals aged 2 months to 55 years and is administered intramuscularly.

Key Features

• Active immunization against meningococcal disease
• Effective for serogroups A, C, Y, and W-135
• Intramuscular injection

Version/Model

• Single-Dose Vial

Technical Specifications

• Volume 0.5 mL
• Storage Requires refrigeration

Application or Use Case

• Recommended for individuals aged 2 months to 55 years

Typical User/Industry Profile

• Healthcare providers and patients requiring meningococcal vaccination

About the Brand

GSK Menveo is a trusted brand in the field of vaccines, known for its innovative approach to preventing meningococcal disease. The brand is committed to providing effective immunization solutions to protect individuals from serious bacterial infections.